Healthy Living After Stroke: An Online Intervention For Improving Stroke Survivor Health Behaviours And Quality Of Life
Funder
National Health and Medical Research Council
Funding Amount
$590,958.00
Summary
This study will test whether an online healthy lifestyles program helps survivors of stroke to live healthier lives, improve their quality of life and prevent a second stroke.
Post-stroke Hyperglycaemia – Treatment With Exenatide In Acute Ischaemic Stroke (TEXAIS) Trial
Funder
National Health and Medical Research Council
Funding Amount
$1,266,149.00
Summary
Raised blood glucose levels (hyperglycaemia) after a stroke is common. It reduces the efficacy of stroke treatments and results in worse outcomes. Insulin is not useful as a treatment for this as it causes frequent hypoglycaemia and does not improve clinical outcomes. Exenatide is a common diabetes drug that is simple to use and lowers blood glucose without hypoglycaemia. It will be tested in the Treatment with Exenatide in Acute Ischaemic Stroke (TEXAIS) trial.
An Australasian, Multi-centre, Randomized, Double-blind, Placebo-controlled Trial Of The Efficacy Of Fluoxetine In Improving Functional Recovery After Acute Stroke
Funder
National Health and Medical Research Council
Funding Amount
$2,306,367.00
Summary
Stroke is one of the top three causes of disability. Treatments that improve recovery after stroke are lacking. We reviewed the world literature and found a number of very small studies which, together, suggest that the antidepressant drug, fluoxetine, may improve the recovery in stroke patients. AFFINITY is a large trial in 1600 Australians and New Zealanders with stroke which aims to find out whether taking fluoxetine for 6 months after a stroke improves recovery compared to a placebo.
Very Early Rehabilitation In SpEech: An RCT Of Aphasia Therapy After Stroke
Funder
National Health and Medical Research Council
Funding Amount
$742,000.00
Summary
Aphasia affects one in three stroke survivors. It interferes with talking, understanding speech, reading and writing. Aphasia is devastating. Research suggests that very early aphasia therapy improves recovery of talking and understanding. However, over 70% of people with aphasia do not get very early treatment. This study promotes a “use it” or “lose it” approach to brain recovery and aims to show that very early aphasia therapy is beneficial and cost effective.
Tenecteplase Versus Alteplase For Stroke Thrombolysis Evaluation (TASTE) Trial
Funder
National Health and Medical Research Council
Funding Amount
$4,180,030.00
Summary
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) is an Australian-led international randomised trial designed to generate practice-changing evidence by translating the advanced imaging treatment selection approach used in our previous pilot studies. TASTE aims to confirm the superiority of the new-generation clot-dissolving agent, tenecteplase, over the standard agent, alteplase, in the broad group of stroke patients eligible for acute clot-dissolving treatment.
Arterial Spin Labeling Perfusion MR Imaging Of Tissue Pathophysiology In Stroke
Funder
National Health and Medical Research Council
Funding Amount
$402,604.00
Summary
It was estimated that in 2012 there were 420,000 Australians living with disability caused by stroke. This project intends to develop a practical treatment selection approach using advanced imaging to target likely treatment responders which could result in more patients living disability free from improved diagnosis and individualised tailoring of acute interventions using MR imaging. The ultimate aim of this project is the translation and implementation of practical advanced imaging stroke.
Targeted Delivery Of CD39 To Ischaemic Brain Improves Outcomes In Stroke
Funder
National Health and Medical Research Council
Funding Amount
$895,780.00
Summary
Stroke is most likely caused by a clot in one of the large blood vessels supplying the brain. The approach is to save the 'at-risk' area of brain with drugs that break-down clots and by manual removal of clots. These treatments are limited by timely access within 4.5 hours to larger hospitals. We are trialing a new drug that protects the brain better on its own and may add to the benefit of current treatments. Moreover, it can be given in any rural setting.
Neural Mechanisms Of Language Facilitation In Aphasia Due To Transcranial Direct Current Stimulation.
Funder
National Health and Medical Research Council
Funding Amount
$523,192.00
Summary
This project will assess the underlying neural mechanisms by which neurostimulation improves impaired language functions after stroke (aphasia). This will be accomplished by using a novel combination of functional magnetic resonance imaging and simultaneous transcranial direct current stimulation (tDCS) administered to different brain regions. These studies will provide crucial information necessary to optimise future clinical trials that combine tDCS with language therapy.
A Randomised Double Blind, Placebo-controlled Study Of Nefiracetam In Patients With Post- Stroke Apathy
Funder
National Health and Medical Research Council
Funding Amount
$865,271.00
Summary
A wide range of emotional and cognitive disturbances are observed following stroke. Apathy is expressed by diminished initiation and poor persistence on tasks, lack of interest, emotional indifference and low social engagement. Our preliminary study has suggested that the medication nefiracetam significantly improves apathy among stroke patients. The main aim of our project is to conduct a large scale study to determine whether nefiracetam improves apathy in patients with stroke lesions.
Circuit Class Therapy For Rehabilitation Clients. A Pragmatic Randomized Controlled Trial Of Therapy Intensity (CIRCIT).
Funder
National Health and Medical Research Council
Funding Amount
$526,361.00
Summary
Loss of independence is common after stroke, and may lead to reduced quality of life and admission to nursing home care. We will investigate if an increased amount of rehabilitation following stroke leads to improved mobility. Two ways of delivering more intense rehabilitation will be compared with usual care to find out which leads to improved physical mobility, and how they compare economically. This will allow health service providers to optimise services and will benefit people with stroke.